Citi Upgrades Hologic (HOLX) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Citi Downgrades Bio-Rad Labs (BIO) to Neutral
April 3, 2024 5:39 AM EDTCiti analyst Patrick Donnelly downgraded Bio-Rad Labs (NYSE: BIO) from Buy to Neutral with a price target of $365.00 (from $400.00).
The analyst comments "We downgrade BIO to Neutral (TP $365) and upgrade HOLX to Buy (TP $95) and SHC to Buy/HR (TP $16). For BIO, visibility remains limited on the ability to achieve its Life... More
